Rakshit Pharmaceuticals is an API manufacturer based in India. It holds 5 active US drug master files and 8 valid CEPs across a filed portfolio of 10 molecules. Its GMP standing is certified by EMA. Customs aggregates show $8.1M of exports covering 401 molecules to 37 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Anakapalli, India | Not on file |
| Anakapalli District, India | Not on file |
| Vishakhapatnam, India | Not on file |
| Visakhapatnam, India | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Azathioprine | EDQM, SFDA (Saudi Arabia), US FDA | 3 |
| Mycophenolate Mofetil | EDQM, US FDA | 2 |
| Mycophenolic Acid | EDQM, US FDA | 2 |
| Pantoprazole | EDQM, SFDA (Saudi Arabia) | 2 |
| Tadalafil | EDQM, SFDA (Saudi Arabia) | 2 |
| Avanafil | US FDA | 1 |
| Diacerein | EDQM | 1 |
| Famotidine | EDQM | 1 |
| Sildenafil | EDQM | 1 |
| Vardenafil | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| CDSCO (India) | 1 | None |
| EMA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $1.5M | 19 |
| 2025 | Not reported | $8.1M | 37 |
| 2024 | Not reported | $10.0M | 34 |
| 2023 | Not reported | $13.3M | 38 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Rakshit Pharmaceuticals comes back tiered against every other supplier able to file there.
Start for free